《华尔街日报》Trialswas launched with the aim of improving the quality and reporting of randomized controlled trials. With the recent publication of the updatedCONSORT guidelines, there has been a growing emphasis within the clinical trials community on complete and accurate reporting. Although there is stillmuch work to be done,Trialshas been gaining recognition in the peer reviewed literature for its innovative approach to publishing clinical trials.

Theauthor’s toolkitrecently published inCurrent Medical Research and Opinionshares the journal’s view that all results should be reported regardless of outcome, and recognizesTrialsas a journal that encourages the publication ofnegative results. In the BMJ,Peter Gøtzsche and colleaguescommend the journal’s approach to promoting the discussion of methodological issues by publishingcritical commentariesof published trials.

This recognition ofTrialsin the literature reflects the journal’s increasing importance in the field. By striving to achieve the goals set out in itslead editorialand actively promoting high-quality reporting,Trialsis setting the standard for publishing clinical trials.

Jenny Withers
Assistant Journal Development Editor –Trials